ict01,pembrolizumab
merck,imcheck therapeutics
['ict01', 'pembro', 'eviction', 'imcheck']
#esmo22: announces promising updated safety and patient response data from the completed dose escalation cohort of #ict01 + #pembrolizumab in #evictiontrial presented by during the investigational #immunotherapy session. 
Driving innovation in #ImmuneModulators #BTNlike #butyrophilin #ImmunotherapeuticAntibodies for the treatment of #cancer #InfectiousDisease & #AutoimmuneDisease